Home/Filings/4/0001567619-20-020716
4//SEC Filing

ALBRECHT DETLEF 4

Accession 0001567619-20-020716

CIK 0001692830other

Filed

Dec 6, 7:00 PM ET

Accepted

Dec 7, 6:01 PM ET

Size

5.6 KB

Accession

0001567619-20-020716

Insider Transaction Report

Form 4
Period: 2020-12-03
ALBRECHT DETLEF
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-12-03+80,00080,000 total
    Exercise: $4.60Exp: 2030-12-03Common Stock (80,000 underlying)
Footnotes (1)
  • [F1]Twenty Five Percent (25%) of the shares subject to the option vest one year measured from December 3, 2020 and the remaining shares subject to the option vest in 36 successive, equal monthly installments thereafter, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

Documents

1 file

Issuer

Satsuma Pharmaceuticals, Inc.

CIK 0001692830

Entity typeother

Related Parties

1
  • filerCIK 0001286642

Filing Metadata

Form type
4
Filed
Dec 6, 7:00 PM ET
Accepted
Dec 7, 6:01 PM ET
Size
5.6 KB